Skip to Content

Join the 'Thrombotic / Thromboembolic Disorder' group to help and get support from people like you.

Thrombotic / Thromboembolic Disorder News

Related terms: Budd-Chiari syndrome, Hepatic vein obstruction, Budd-Chiari, Factor V Leiden, Prothrombin G20210A Mutation

FDA Approves Defitelio (defibrotide sodium) for Hepatic Veno-Occlusive Disease Following Hematopoietic Stem-Cell Transplantation

Posted 31 Mar 2016 by Drugs.com

March 30, 2016 – The U.S. Food and Drug Administration today approved Defitelio (defibrotide sodium) to treat adults and children who develop hepatic veno-occlusive disease (VOD) with additional kidney or lung abnormalities after they receive a stem cell transplant from blood or bone marrow called hematopoietic stem cell transplantation (HSCT). This is the first FDA-approved therapy for ...

Drug May Be Antidote to Bleeding Tied to Blood Thinner Pradaxa

Posted 22 Jun 2015 by Drugs.com

MONDAY, June 22, 2015 – The new blood thinner Pradaxa (dabigatran) is being widely used, but it comes with one serious drawback: rare but dangerous cases of sudden, uncontrolled bleeding in patients. Now, a new study finds than an experimental, injected drug called idarucizumab could be used to quickly stop that bleeding. "Idarucizumab completely reversed the anticoagulant [bleeding] effect of ...

Most Treatments for Blood Clots Appear Safe, Effective

Posted 16 Sep 2014 by Drugs.com

TUESDAY, Sept. 16, 2014 – Almost all the various treatment options for blood clots that form in veins are equally safe and effective, new research shows. In exploring the safety and effectiveness of treatments for such blood clots as deep vein thrombosis or pulmonary embolism (blood clot in a lung), Canadian researchers analyzed outcomes associated with eight blood-thinning options, including ...

FDA Medwatch Alert: Heparin Sodium, 1,000 USP Heparin Units/500 mL (2 USP Heparin Units/mL), In 0.9 percent Sodium Chloride Injection, 500 mL by Hospira: Recall - Particulate Matter

Posted 15 Sep 2014 by Drugs.com

ISSUE: Hospira, Inc. announced a voluntary nationwide user-level recall of one lot of Heparin Sodium, 1,000 USP Heparin Units/500 mL (2 USP Heparin Units/mL), in 0.9% Sodium Chloride Injection, 500 mL, NDC 0409-7620-03 Lot 41-046-JT with expiration date of 01NOV 2015. This action is due to one confirmed customer report of particulate in a single unit. The foreign particle was confirmed by Hospira ...

C-Sections Linked to Doubled Risk for Blood Clots

Posted 26 Aug 2011 by Drugs.com

FRIDAY, Aug. 26 – The risk of thromboembolism – a potentially fatal condition in which blood clots block blood flow causing damage to the organs – is higher during pregnancy, experts warn. And having a Caesarean section nearly doubles that risk, according to experts at the American College of Obstetricians and Gynecologists. As a result, the group issued a new recommendation that all women ...

Ask a Question

Further Information

Related Condition Support Groups

Thromboembolic Disorder

Related Drug Support Groups

heparin, Activase, alteplase, streptokinase, Cathflo Activase, Abbokinase, argatroban, urokinase, Kabikinase, Streptase, Abbokinase Open-Cath, Acova, Heparin Sodium, Kinlytic